CASE REPORT
|
doi:10.20944/preprints202101.0249.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
Crizotinib; Anaplastic Large Cell Lymphomas ALK+; bridge therapy in NHL ALK+; ALK+ patients; anticancer therapy
Online: 13 January 2021 (12:58:38 CET)